Category: Upcoming IPO

upcoming ipo, new ipo, upcoming ipo 2021, latest ipo, recent ipo, upcoming ipo list, upcoming ipo calendar, new ipo list, new ipo today, next ipo, forthcoming ipo, ipos today, new ipo launch, coming ipo, ipo watch upcoming ipo, upcoming ipo nse, upcoming ipo zerodha, latest ipo news, chittorgarh ipo,upcoming ipo chittorgarh,ipo watch upcoming ipo, ipowatch

Exxaro Tiles IPO Date, Details, Price, GMP

Upcoming IPO

Exxaro Tiles Limited is established in 2008 by Mr. Mukeshkumar Patel, Mr. Kirankumar Patel, Mr. Dineshbhai Patel, and Mr. Rameshbhai Patel are the company promoters.

Exxaro Tiles IPO It is involved in the production and sale of vitrified tiles. Double Charge Vitrified Tiles (double layer pigment) and Glazed Vitrified Tiles are manufactured from ceramic elements such as clay, quartz, and feldspar. Its product line includes over 1000 distinct tile designs in 6 sizes. Some of the company’s well-known products are the Topaz Series, Galaxy Series, and High Gloss Series.

Read :- Upcoming IPO 2021

Its goods are used in big infrastructure projects such as residential, educational, commercial, hotels, hospitals, government, builders or developers, religious organizations, and so on. It also sells tiles to many nations across the world, including Poland, Bosnia, the United States, and others.

Competitive advantages

  • A variety of vitrified tile design options in various sizes are available.
  • With over 2,000 registered dealers, the company has a large dealer network.
  • PAN India has a strong presence in all 27 Indian states.
  • International presence, with exports to over 13 countries worldwide.
    • Exxaro Tiles IPO details
    Subscription Dates 4-6 2021
    Price Band 118-120 Rs Per Share
    Offer For Sale 26.86 crore
    Fresh issue 134.23 crore
    Total IPO size 161.09 crore
    Minimum bid (lot size) 125 Rs Share
    Face Value 10 Rs share
    Retail Allocation 35%
    Listing On NSE, BSE
    Exxaro Tiles IPO Market Lot
    Lot No of Shares Amount
    Minimum 1 125 Shares 15,000 Rs
    Maximum 13 1625 Shares 195,000 Rs

    Financial Record of the last year (In Million)

    Financial Period : 31-MAR-21
    Total Assets : 3,693.14
    Total Revenue : 2,598.53
    Profit After Tax : 152.23
    Earnings Per Share (EPS) FY2020 : 3.36 Rs

    Registrar of Exxaro Tiles IPO

    Link Intime India Private Limited
    C-101, 1st Floor, 247 Park
    Lal Bahadur Shastri Marg,
    Vikhroli (West) Mumbai – 400 083
    Phone: +91 22 4918 6200
    Fax: +91 22 4918 6195
    Website: http://www.linkintime.co.in

    Exxaro Tiles Contact Details

    Exxaro Tiles Limited
    Survey No. 169 & 170, Vavdi Harsol Road, At & Po.
    Mahelav, Taluka: Talod, Sabarkantha – 383 305
    Phone: +02772-350555
    Website: http://www.exxarotiles.com/

    Exxaro Tiles IPO Lead Managers

    Pantomath Capital Advisors Pvt Ltd

    Krsnaa Diagnostics IPO Date, Details, Price, GMP

    Upcoming IPO

    Krsnaa Diagnostics is established in 2010 by Rajendra Mutha is the company founder.

    krsnaa Diagnostics IPO : It is one of India’s fastest-growing diagnostic chains. The firm provides a comprehensive variety of diagnostic services to private and governmental hospitals, medical colleges, and community health centers, including imaging/radiology services (X-rays, MRI, etc.), regular clinical laboratory testing, pathology, and teleradiology services.

    Krsnaa Diagnostics IPO details
    Subscription Dates 4-6 August 2021
    Price Band 933 -954 Rs Per Share
    Offer For Sale 813.33 crore
    Fresh issue 400 crore
    Total IPO size 1,213 crore
    Minimum bid (lot size) 15 Rs Share
    Face Value 5 Rs share
    Retail Allocation 35%
    Listing On NSE, BSE
    Krsnaa Diagnostics IPO Market Lot
    Lot No of Shares Amount
    Minimum 1 15 Shares 14,310 Rs
    Maximum 13 195 Shares 1,86,030 Rs

    Financial Record of the last year (In Million)

    Financial Period : 31-Dec-20
    Total Assets : 6,345.17
    Total Revenue : 5,627.01
    Profit After Tax : 1,959.30
    Earnings Per Share (EPS) FY2021 : -97.16 RS

    Registrar of Krsnaa Diagnostics IPO

    KFintech Private Limited
    KFintech, Tower-B, Plot No 31 & 32,
    Financial District, Nanakramguda, Gachibowli,
    Hyderabad, Telangana India – 500 032.
    Phone: 04067162222, 04079611000
    Website: https://karisma.kfintech.com/

    Krsnaa Diagnostics Contact Details

    Krsnaa Diagnostics Limited
    S.No. 243, A-Hissa No. 6, CTS No. 4519, 4519/1,
    Chinchwad, Taluka – Haveli, Pune – 411 019
    Phone: +91 20 4695 4695
    Website: https://krsnaadiagnostics.com/

    Krsnaa Diagnostics Lead Managers

    DAM Capital Advisors Ltd (Formerly IDFC Securities Ltd)
    Equirus Capital Private Limited
    IIFL Holdings Limited
    JM Financial Consultants Private Limited

    Nuvoco Vistas IPO Date, Details, GMP, Review

    Upcoming IPO

    Nuvoco Vistas Corporation Ltd is established in 1999 by Niyogi Enterprises Pvt Ltd and Dr. Karsanbhai K Patel are the company promoters.

    Nuvoco Vistas IPO:- It is a Subsidiary of the Nirma Group. Nuvoco Vistas is one of India’s major concrete makers.It provides a diverse range of goods, including cement, Ready-mix Concrete (RMX), and contemporary building supplies such as adhesives, wall putty, dry plaster, cover blocks, and more.

    Check :- Upcoming IPO 2021

    The company offers its products in two markets: trade (individual house purchasers) and non-trade (other businesses) (institutional and bulk buyers). It has a robust distribution network that includes 15,969 dealers and 225 CFAs.

    Its cement facilities have an aggregate installed capacity of 22.32 MMTPA and are located in the states of West Bengal, Bihar, Odisha, Chhattisgarh, and Jharkhand in East India, and Rajasthan and Haryana in North India.

    Nuvoco Vistas IPO Details
    Subscription Dates 9-11 August 2021
    Price Band 560-570 Rs Per Share
    Offer For Sale 3500 crore
    Fresh issue 1500 crore
    Total IPO size 5,000 crore
    Minimum bid (lot size) 26 Rs Share
    Face Value 10 Rs share
    Retail Allocation 35%
    Listing On NSE, BSE
    Nuvoco Vistas Market Lot
    Lot No of Shares Amount
    Minimum 1 26 Shares 14,820 Rs
    Maximum 13 338 Shares 192,660 Rs

    Financial Record of the last year (In Million)

    Financial Period : 31-Mar-21
    Total Assets : 1,99,075.70
    Total Revenue : 75,226.93
    Profit After Tax : 259.19
    Earnings Per Share (EPS) FY2021 : -0.82

    Registrar of Nuvoco Vistas IPO

    Link Intime India Private Limited
    C-101, 1st Floor, 247 Park
    Lal Bahadur Shastri Marg,
    Vikhroli (West) Mumbai – 400 083
    Phone: +91 22 4918 6200
    Fax: +91 22 4918 6195
    Email: [email protected]
    Website: http://www.linkintime.co.in

    Nuvoco Vistas Contact Details

    Nuvoco Vistas Corporation Ltd
    Equinox Business Park, Tower 3, East Wing,
    4th Floor, LBS Marg, Kurla (West),
    Mumbai – 400 070
    Phone: +91 22 6769 2500
    Email: [email protected]
    Website: http://www.nuvoco.com/

    Rolex Rings IPO Date, Details, Price, GMP

    Upcoming IPO

    Rolex Rings is established in 2003 by Rupesh Dayashankar Madeka, Jiten Dayashankar Madeka, Manesh Dayashankar Madeka, Pinakin Dayashankar Madeka, and Bhautik Dayashankar Madeka are the company promoters.

    Rolex Rings is a global manufacturer and supplier of hot rolled forged and machined bearing rings, as well as automotive components for vehicle segments such as two-wheelers, passenger vehicles, commercial vehicles, off-highway vehicles, electric vehicles), industrial machinery, wind turbines, and railways.

    The firm sells its products to automotive companies and prominent bearing manufacturers on a domestic and worldwide scale, including SRF India, Schaeffler India, Timken India, and others. In fiscal 2020, it exported bearing rings and automobile components to 17 countries, including France, Italy, Germany, Thailand, the Czech Republic, the United States, and others.

    Currently, the company has three production units in Rajkot, each with 22 forging lines and a total installed capacity of 1,44,750 MTPA.

    Read :- Rolex Rings IPO GMP

    Rolex Rings IPO Competitive advantages

  • Among India’s biggest forging firms.
  • Excellent manufacturing capability.
  • A diverse product portfolio.
  • A revenue base that is geographically diverse.
  • A strong and consistent track record of financial achievement.
    • Rolex Rings IPO details
    Subscription Dates 28-30 July 2021
    Price Band 880-900 Rs Per Share
    Offer For Sale 675 crore
    Fresh issue 56 crore
    Total IPO size 731 crore
    Minimum bid (lot size) 16 Rs Share
    Face Value 10 Rs share
    Retail Allocation 35%
    Listing On NSE, BSE
    Rolex Rings Market Lot
    Lot No of Shares Amount
    Minimum 1 16 Shares 14,400 Rs
    Maximum 13 208 Shares 1,87,200 Rs

    Financial Record of the last year (In Million)

    Financial Period : 30-Sep-20
    Total Assets : 6,710.26
    Total Revenue : 2,254.59
    Profit After Tax : 253.14
    Earnings Per Share (EPS) FY2020 : 22.08 Rs

    Registrar of Rolex Ring IPO

    Link Intime India Private Limited
    C-101, 1st Floor, 247 Park
    Lal Bahadur Shastri Marg,
    Vikhroli (West) Mumbai – 400 083
    Phone: +91 22 4918 6200
    Fax: +91 22 4918 6195
    Email: [email protected]
    Website: http://www.linkintime.co.in

    Rolex Ring Contact Details

    Rolex Rings Limited
    B/h. Glowtech Steel Private Limited
    Gondal Road, Kotharia, Rajkot, 360 004
    Phone: 0281 6699677/577
    Email: [email protected]
    Website: http://www.rolexrings.com

    Tatva Chintan Pharma IPO Details

    Upcoming IPO

    Tatva Chintan Pharma Chem is established in 1996 by Ajaykumar Mansukhlal Patel, Chintan Nitinkumar Shah, and Snehkar Rasiklal Somani are the company promoters.

    Tatva Chintan Pharma Chem Limited produces structure directing agents (SDAs), phase transfer catalysts (PTCs), pharmaceutical and agricultural intermediates, and other speciality chemicals. It is one of India’s leading manufacturers of SDAs for zeolites. Automotive, petroleum, agrochemicals, dyes & pigments, paints and coatings, pharmaceutical, personal care, and other industries are served by the company. Its products are sold not just in India, but also in more than 25 countries throughout the world, including the United States, Germany, South Africa, China, and the United Kingdom. Total export provided 76 percent of total revenue from operations in FY 2020.

    Check :- IPO Allotment Status

    Among the company’s customers are Merck, Bayer AG, Ipox Chemicals, Laurus labs, Navin Fluorine International Limited, Atul Limited, Otsuka Chemicals, SRF Limited, Hawks Chemical Company, Firmenich Aromatics Prod Pvt Ltd, and Divi’s laboratories. It currently operates two manufacturing sites in Gujarat: Ankleshwar and Dahej.We have shared the details of tatva chintan pharma ipo and grey market premium gmp.

    Competitive advantages

  • Structure directing agents and phase transfer catalysts from a leading company.
  • Product portfolio with a wide range of options.
  • With a customer base spanning multiple industries, we have a global market presence.
  • A industrial complex in Gujarat that is strategically placed near the Hazira Port.
  • Team of seasoned promoters and managers.
  • A proven track record of financial success.
    • Tatva Chintan Pharma IPO details
    Subscription Dates 16-20 July 2021
    Price Band 1073-1083 Rs Per Share
    Offer For Sale 275 crore
    Fresh issue 225 crore
    Total IPO size 500 crore
    Minimum bid (lot size) 13 Rs Share
    Face Value 10 Rs share
    Retail Allocation 35%
    Listing On NSE, BSE
    Tatva Chintan Pharma Market Lot
    Lot No of Shares Amount
    Minimum 1 13 Shares 14,079 Rs
    Maximum 14 182 Shares 1,97,106 Rs

    Financial Record of the last year (In Million)

    Financial Period : 31-Mar-21
    Total Assets : 3,148.03
    Total Revenue : 3,062.92
    Profit After Tax : 522.62
    Earnings Per Share (EPS) FY2021 : 18.81 Rs

    Registrar of Tatva Chintan IPO

    Link Intime India Private Limited
    C-101, 1st Floor, 247 Park
    Lal Bahadur Shastri Marg,
    Vikhroli (West) Mumbai – 400 083
    Phone: +91 22 4918 6200
    Fax: +91 22 4918 6195
    Website: http://www.linkintime.co.in

    Tatva Chintan Contact Details

    Tatva Chintan Pharma Chem Limited
    Plot No. 353, Makarpura GIDC,
    Vadodara, Gujarat – 390 010
    Phone: +91 75748 48533
    Email: [email protected]
    Website: www.tatvachintan.com

    Zomato IPO Details,GMP, Allotment Status

    Upcoming IPO

    Zomato is an online food delivery platform founded by Pankaj Chaddah and Deepinder Goyal in 2008. Info Edge(18.6%),Uber (9.1%),Alipay Singapore (8.3%),Antfin Singapore (8.2%) are some current Share Holders of Zomato.

    There are 1,31,233 restaurants and 1,61,637 delivery partners connected with Zomato.

    Competitive advantages

  • Growing Customer Base
  • Top popular food delivery platforms
  • Consumer brand equity is well-known in India.
  • On-demand hyperlocal delivery network that is widespread and efficient.

    • News :- Info Edge reduces the size of Zomato IPO by half, to 375 crore

    Read Details :- Zomato raised Rs 4,196.51 crore from 186 anchor investors at Rs 76

    Read Details :- Zomato IPO GMP

    Read Details :- Zomato IPO Allotment Status

    Read Details :- Zomato Ltd IPO Subscription Status [Live]

    Key Risk

  • It has a history of net losses and anticipates increased expenses in the future
  • Covid-19 pandemic has had and could impact the business, cash flows, financial condition and results of operations.
  • Its revenue may decrease and the business may be adversely affected if it fails to retain existing restaurant partners, customers, or delivery partners or fails to add new restaurant partners, delivery partners, or customers to its portfolio in a cost-effective manner.
    • Zomato IPO details
    Subscription Dates 14-16 July 2021
    Price Band 72-76 Rs Per Share
    Offer For Sale 375 crore
    Fresh issue 9,000 crore
    Total IPO size 9,375 crore
    Minimum bid (lot size) 195 Rs Share
    Face Value 1 Rs share
    Retail Allocation 10%
    Listing On NSE, BSE
    Zomato Market Lot
    Lot No of Shares Amount
    Minimum 1 195 Shares 14820 Rs
    Maximum 13 2535 Shares 1,92,660 Rs

    Financial Record of the last year (In Million)

    Financial Period : 31-Dec-20
    Total Assets : 69,883.21
    Total Revenue : 13,676.55
    Profit After Tax : 6,821.99
    Earnings Per Share (EPS) FY2021 : -5.09 Rs

    Registrar of Zomato IPO

    Link Intime India Private Limited
    C-101, 1st Floor, 247 Park
    Lal Bahadur Shastri Marg,
    Vikhroli (West) Mumbai – 400 083
    Phone: +91 22 4918 6200
    Fax: +91 22 4918 6195
    Email: [email protected]
    Website: http://www.linkintime.co.in

    Zomato Contact Details

    Zomato Limited
    Ground Floor, Tower C,
    Vipul Tech Square, Golf Course Road,
    Sector 43, Gurgaon 122 009
    Phone: +91 124 426 8565
    Email: [email protected]
    Website: www.zomato.com

    Info Edge reduces the size of Zomato IPO by half, to 375 crore

    Upcoming IPO

    Zomato, an online restaurant discovery and food ordering service, is set to raise $1.2 billion in an initial public offering (IPO), paving the way for one of the most eagerly anticipated share sales in recent history.

    However, according to the market observers, Zomato IPO GMP (grey market premium) today is ₹15-20, which reflects the bullish expectations of the markets in regard to the construction company’s public issue.

    Info Edge, one of the largest shareholders in the food-delivery app Zomato, announced that it is reducing the size of its offer for sale (OFS) in Zomato’s IPO to 375 crore, down from 750 crore previously planned.

    Read :- Zomato IPO Details, Price, Date, GMP, Review

    Zomoto said The company’s revised OFS would consist of up to 3,750 million equity shares held by the company in Zomato, the terms and conditions of which will be specified in the red herring prospectus and the prospectus filed in relation to the offer, as well as other Offer related documents and agreements when an exchange filing on 4th July.

    In April, Zomato filed a draught red herring prospectus (DRHP) with market regulator SEBI, proposing an IPO of Rs 8,250 crore. According to the company, it will issue new equity shares worth Rs 7,500 crore, with early backer Info Edge India Ltd selling a stake worth Rs 750 crore in Zomato’s upcoming public offering.

    Glenmark Life Sciences IPO Details, Date, GMP, Review

    Upcoming IPO

    Glenmark Life Sciences Limited is established in 2011 by Glenmark Pharmaceuticals Limited are the promoters of the company.

    It is the world’s largest producer of Active Pharmaceutical Ingredients (APIs). The company creates, manufactures, and distributes high-quality APIs for cardiovascular disease (CVS), central nervous system disease (CNS), pain management, and diabetes, as well as gastrointestinal disorders, anti-infectives, and other therapeutic areas.

    It also provides contract development and manufacturing operations (CDMO) to specialty pharmaceutical companies.

    Updates :- Glenmark Life Sciences Limited IPO GMP / Grey market premium

    Its products are sold in India as well as in other countries such as Europe, North America, Latin America, Japan, and so on. It currently operates four manufacturing facilities in Gujarat (Ankleshwar and Dahej) and Maharashtra (Mohol and Kurkumbh), with an annual installed capacity of 725.8 KL as of December 31, 2020.

    Competitive advantages

  • Leading producer of specialised APIs for chronic therapeutic areas such as CVS, CNS, diabetes, and pain management.
  • Products can be exported to Europe, Latin America, North America, Japan, and the rest of the world.
  • Strong relationships with the world’s leading generic companies.
  • Proven track record of financial success.
  • Manufacturing of high-quality products with R&D infrastructure.
    • Glenmark Life Sciences Limited IPO details
    Subscription Dates 27-29 July 2021
    Price Band 695-720 Rs Per Share
    Offer For Sale 453.60 crore
    Fress Issue size 1,060 crore
    Total IPO size 1,513.60 crore
    Minimum bid (lot size) 20 Rs Share
    Face Value 2 Rs share
    Retail Allocation 35%
    Listing On NSE, BSE
    Glenmark Life Sciences Market Lot
    Lot No of Shares Amount
    Minimum 1 20 Shares 14400 Rs
    Maximum 13 260 Shares 187,200 Rs

    Financial Record of the last year (In Million)

    Financial Period : 31-Mar-21
    Total Assets : 19,970.75
    Total Revenue : 18,859.76
    Profit After Tax : 3,515.81
    Earnings Per Share (EPS) FY2021 : 32.61 Rs

    Registrar of Glenmark Life Sciences IPO

    KFintech Private Limited
    KFintech, Tower-B, Plot No 31 & 32,
    Financial District, Nanakramguda, Gachibowli,
    Hyderabad, Telangana India – 500 032.
    Phone: 04067162222, 04079611000
    Email: [email protected]
    Website: https://karisma.kfintech.com/
    Website: http://www.linkintime.co.in

    Glenmark Life Sciences Contact Details

    Glenmark Life Sciences Limited
    Plot No. 170-172, Chandramouli Industrial Estate,
    Mohol Bazarpeth, Solapur 413 213,
    Phone: +91 2189 234456/ +91 2189
    Email: [email protected]
    Website: http://www.glenmarklifesciences.com/

    Clean Science and Technology IPO Details, Date, GMP, Review

    Upcoming IPO

    Clean Science and Technology Limited is established in 2003 by Ashok Ramnarayan Boob, Krishnakumar Ramnarayan Boob, Siddhartha Ashok Sikchi and Parth Ashok Maheshwari are the promoters of the company.

    Clean Science and Technology is one of the few companies in the world that is solely focused on developing newer technologies through in-house catalytic processes, allowing it to become the largest manufacturer of certain specialty chemicals in terms of manufacturing capacity.

    Performance Chemicals (i.e. MEHQ, BHA, and AP), Pharmaceutical Intermediates (i.e. Guaiacol and DCC), and FMCG Chemicals are among the functionally critical specialty chemicals manufactured by the company (i.e. 4-MAP and Anisole).

    Updates :- Clean Science IPO GMP / Grey market premium

    Its products are used as key starting materials, inhibitors, or additives for regulated market products. Bayer AG, SRF Limited, Gennex Laboratories Limited, Nutriad International NV, and Vinati Organics Limited are among its major clients.

    Competitive Advantages

  • Ansole, 4-MAP, MEHQ, BHA, DCC, and other chemicals are supplied by this global leader.
  • To export products, the manufacturing facility is strategically located near the JNPT port.
  • Long-term relationships with key customers are essential.
  • Financial performance track record that has been consistent.
  • International presence with exports to several countries, including China, the United States, Korea, Japan, and Taiwan.
    • Clean Science IPO Details
    Subscription Dates 7-9 July 2021
    Price Band 880 – 900 Rs Per Share
    Offer For Sale 1,546.6 crore
    Total IPO size 1,546.6 crore
    Minimum bid (lot size) 16 Rs Share
    Face Value 1 Rs share
    Retail Allocation 35%
    Listing On NSE, BSE
    Clean Science Market Lot
    Lot No of Shares Amount
    Minimum 1 16 Shares 14400 Rs
    Maximum 13 208 Shares 187,200 Rs

    Financial Record of the last year (In Million)

    Financial Period : 31-Dec-20
    Total Assets : 5,711.85
    Total Revenue : 3,984.64
    Profit After Tax : 1,452.65
    Earnings Per Share (EPS) FY2021 : 18.68 Rs

    Registrar of Clean Science IPO

    Link Intime India Private Limited
    C-101, 1st Floor,
    247 Park Lal Bahadur Shastri Marg,
    Vikhroli (West) Mumbai – 400 083
    Phone: +91 22 4918 6200
    Fax: +91 22 4918 6195
    Email: [email protected]
    Website: http://www.linkintime.co.in

    Clean Science Contact Details

    Clean Science and Technology Limited
    Office No. 503, Pentagon Tower P-4,
    Magarpatta City, Hadapsar,
    Pune 411 013 Maharashtra
    Phone: +91 20 26899953
    Email: [email protected]
    Website: www.cleanscience.co.in

    G R Infraprojects Limited IPO Details, Date, GMP, Review

    Upcoming IPO

    G R Infraprojects is established in 1995 by Vinod Kumar Agarwal, Ajendra Kumar Agarwal, Purshottam Agarwal, and Lokesh Builders Private Limited are the promoters of the company. .

    G R Infraprojects Limited (GRIL) is an integrated Road engineering, Procurement and Construction (EPC) company proficient in designing and constructing various road/highway projects, across 15 states in India. It has recently diversified into railway projects.

    Read :- Prabhudas Lilladher Detail Reports

    The company’s individual promoters have more than 25 years of experience in construction industry with an exceptional track record of timely executing projects. Prior to the incorporation, individual promoters were associated with M/s.Gumani Ram Agarwal, a partnership firm engaged in construction business, later acquired by GRIL in FY1996.

    Updates :- G R Infraprojects IPO GMP / Grey market premium

    The company’s primary business operations are broadly divided into three categories: 1) civil construction activities, which include EPC services; 2) development of roads and highways on a BOT & HAM basis, including O&M during concession period; and 3) manufacturing activities, under which they process bitumen, manufacture thermoplastic road-marking paint, electric poles, road signage and fabricate and galvanize metal crash barriers, for captive use in their own projects as well as for sale to third parties.

    Competitive Advantages

  • Experienced promoters with a strong track record of project execution.
  • Strong Infra-push specially emphasizing on roads sector.
  • Rising order inflows led to healthy & geographically diversified OB:
  • Monetization of assets to further improve BS position:.

    • Key Risk

  • Change in Government policies on roads would largely impact future prospects
  • Rising competition in roads sector could impact order inflows and margins going ahead
  • High working capital requirements
  • Delays in collection from clients
    • G R Infraprojects Ltd IPO details
    Subscription Dates 7-9 July 2021
    Price Band 828 – 837 Rs Per Share
    Offer For Sale 11,508,704 Equity Shares
    Total IPO size 11,508,704 Equity Shares
    Minimum bid (lot size) 17 Rs Share
    Face Value 5 Rs share
    Retail Allocation 35%
    Listing On NSE, BSE
    G R Infraprojects Ltd Market Lot
    Lot No of Shares Amount
    Minimum 1 17 Shares 14229 Rs
    Maximum 14 196 Shares 199206 Rs
    Shareholding Pattern
    % Pre-Issue Post-Issue
    Promoters 88.0% 12.0%
    Public & Others 86.5% 13.5%

    Financial Record of the last year (In Million)

    Financial Period : 31-Mar-21
    Total Assets : 1,01,160.45
    Total Revenue : 79,069.43
    Profit After Tax : 9,532.21
    Earnings Per Share (EPS) FY2021: 98.6 Rs

    Registrar of G R Infraprojects Ltd IPO

    KFin Technologies Private Limited
    Selenium Tower B, Plot 31-32,
    Gachibowli, Nanakramguda,
    Hyderabad – 500 032, Telangana
    Phone: +91 40 6716 2222
    Fax: +91 40 2343 1551
    Email: [email protected]
    Website: www.kfintech.com

    >G R Infraprojects Ltd Contact Details

    G R Infraprojects Limited
    Revenue Block No. 223, Old Survey No.384 /1, 384/2
    Paiki and 384 / 3, Khata No. 464, Kochariya,
    Ahmedabad, Gujarat – 382220
    Phone: +91 294 248 7370
    Email: [email protected]
    Website: http://www.grinfra.com/

    India Pesticides IPO Details, Date, GMP, Reviews

    Upcoming IPO

    India Pesticides Limited (IPL) is a prominent agrochemicals producer in India, having been founded in 1984. Technicals and Formulations are the two business verticals in which the organisation works. It produces herbicide, fungicide, and active pharmaceutical ingredient technicals (APIs). Folpet, Thiocarbamate, and Herbicide are among the Technicals for which it is the exclusive Indian manufacturer. In addition, the firm produces more than 30 insecticide, fungicide, and herbicide formulations.

    Updates :- India Pesticides IPO Reviews ( Subscribe )

    Technicals, which are primarily exported to more than 20 countries, including Australia, Asia, Africa, and Europe, accounted for 62% of technical segment revenues in Fiscal 2020. Syngentia Asia Pte Ltd, UPL Ltd, ASCENZA AGRO, S.A., Conquest Crop Protection Pty Ltd, Sharda Cropchem Limited, and Stotras Pty Ltd are among the domestic crop protection firms that sell agrochemical formulations.

    Updates :- India Pesticides IPO GMP / Grey market premium

    The company now operates two production sites in Uttar Pradesh, India: UPSIDC Industrial Area at Dewa Road, Lucknow, and Sandila, Hardoi, with a total installed capacity of 19,500 MT for agrochemicals and 6500 MT for formulations.

    Updates :- India Pesticides IPO Subscription Status Today [Live Update]

    Competitive advantages

  • Folpet, Thiocarbamate, and Herbicide Technicals are among the top 5 global players.
  • Product portfolio offers a variety of specialised goods.
  • Market presence on both the domestic and international levels.
  • Financial performance that has been consistent throughout time.
  • Research and development (R&D) capabilities are strong.

    • Company Promoters:

    Anand Swarup Agarwal and The Asa Family Trust are the company promoters.

    India Pesticides IPO Date and Details

    Subscription Dates 23-25 June 2021
    Price Band 290-296 Rs Per Share
    Fresh issue 100 crore
    Offer For Sale 700 Crore
    Total IPO size 800 crore
    Minimum bid (lot size) 50 Rs Share
    Face Value 1 Rs share
    Retail Allocation 35%
    Listing On NSE, BSE

    India Pesticides Market Lot

    Lot No of Shares Amount
    Minimum 1 50 Shares 14,800 Rs
    Maximum 13 650 Shares 192,400 Rs

    Registrar of India Pesticides IPO

    KFin Technologies Private Limited
    Selenium Tower B, Plot 31-32,
    Gachibowli, Nanakramguda,
    Hyderabad – 500 032, Telangana
    Phone: +91 40 6716 2222
    Fax: +91 40 2343 1551
    Email: [email protected]
    Website: www.kfintech.com

    India Pesticides Contact Details

    India Pesticides Limited
    Swarup Cold Storage Compound, Water Works Road, Aishbagh,
    Lucknow 226 004, Uttar Pradesh
    Phone: +91 0522 2653602
    Email: [email protected]
    Website: www.indiapesticideslimited.co

    Krishna Institute ( KIMS ) IPO Details, Price, GMP, Reviews

    Upcoming IPO

    Krishna Institute of Medical Sciences Limited (KIMS) is a one of the largest corporate healthcare groups in AP and Telangana in terms of number of patients treated and treatments offered, according to the CRISIL Report.

    They provide multi-disciplinary integrated healthcare services, with a focus on primary secondary & tertiary care in Tier 2-3 cities and primary, secondary, tertiary and quaternary healthcare in Tier 1 cities. We operate 9 multi-specialty hospitals under the “KIMS Hospitals” brand, with an aggregate bed capacity of 3,064, including over 2,500 operational beds as of December 31, 2020, which is 2.2 times more beds than the second largest provider in AP and Telangana, according to the CRISIL report.

    Subscription Status Live: KIMS IPO Subscription Status Live

    They offer a comprehensive range of healthcare services across over 25 specialties and super specialties, including cardiac sciences, oncology, neurosciences, gastric sciences, orthopaedics, organ transplantation, renal sciences and mother & child care.

    Company Promoters:

    Dr. Bhaskara Rao Bollineni, Rajyasri Bollineni, Dr. Abhinay Bollineni, Adwik Bollineni, and Bollineni Ramanaiah Memorial Hospitals Private Limited are the company promoters.

    KIMS IPO Date, Details, Price and GMP

    Subscription Dates 16-18 June 2021
    Price Band 815 – 825 INR per share
    Fresh issue 200 crore
    Offer For Sale 23,560,538 shares (1,920.18 – 1,943.74 crore)
    Total IPO size 2,120.18 – 2,143.74 crore
    Minimum bid (lot size) 18 share
    Face Value 10 INR per share
    Retail Allocation 10%
    Listing On NSE, BSE

    KIMS IPO Market Lot

    The KIMS IPO minimum market lot is 18 shares With 14,850 ₹ Amount per application.

    Lot No of Shares Amount
    Minimum 1 18 Shares 14,850 Rs
    Maximum 13 234 Shares 1,93,050 Rs

    KIMS IPO GMP & Grey Market Premium

    KIMS IPO GMP Grey market premium has been started today. Check Latest KIMS IPO GMP, Kostak Rates and Subject to Sauda Price here.

    KIMS IPO Prospectus

    KIMS IPO Prospectus Available on BSE and Sebi Website as well as on our Portal. Please click here to Download KIMS IPO Prospectus.

    Aadhar Housing Finance IPO Documents Download
    DRHP Download
    RHP Download

    KIMS IPO Reviews

    Angel Broking – Update Soon
    Choice Broking – Update Soon
    Prabhudas Lilladher – Update Soon

    KIMS IPO Form Download

    KIMS IPO form Available on NSE, BSE Website as well as on our Portal. Please click here to Download KIMS IPO forms.

    KIMS IPO Allotment Date & Details

    Allotment Date 23-June-2024
    Initiation of refunds 24-June -2024
    Transfer of shares to Demat accounts 25-June-2024
    Listing Date 28-June-2024
    Check Allotment Status Click here

    Registrar of KIMS IPO

    KFin Technologies Private Limited
    Selenium Building, Tower B, Plot No. 31-32
    Financial District, Nanakramguda,
    Hyderabad, Rangareddi 500 032
    Telangana, India
    Tel: + 91 40 6716 2222
    E-mail: [email protected]
    Website: www.kfintech.com
    Investor Grievance ID:
    [email protected]
    Contact Person: M. Murali Krishna
    SEBI Registration Number: INR000000221
    #Formerly known as Karvy Fintech Private
    Limited

    KIMS Contact Details

    Krishna Institute Of Medical Sciences Limited
    D. No. 1-8-31/1,
    Minister’s Road,
    Secunderabad – 3,
    Telangana 500 003
    Phone: +91 40 4418 6000
    Email: [email protected]
    Website: www.kimshospitals.com

    Aadhar Housing Finance IPO Lead Managers

    Kotak Mahindra Capital Company
    Axis Capital Limited
    Credit Suisse Securities (India) Private Limited
    IIFL Securities Limited

    Dodla Dairy IPO Details, Price, Reviews

    Upcoming IPO

    Dodla Dairy Limited, founded in 1995, is a South Indian integrated dairy company that specialises in the procurement, processing, distribution, and marketing of milk and other dairy products. It processes and sells milk, including standardised, toned, and double toned milk, as well as dairy products such as curd, butter, ghee, ice cream, and flavoured milk.

    It’s Indian operations are primarily carried out under the brand names “Dodla,” “Dodla Dairy,” and “KC+,” while it serves the international market under the brand names “Dodla Dairy,” “Dairy Top,” and “Dodla+.” The key Indian market segments served by the company are Telangana, Andhra Pradesh, Karnataka, Tamil Nadu, and Maharashtra, while in the international market, it primarily serves Uganda,Kenya.

    Subscription Status Live: Dodla Dairy IPO Subscription Status

    It operates 13 processing plants to convert raw milk into packaged milk and to manufacture dairy-based value-added products. The company has a strong distribution network in India, with 40 sales offices, 3336 distribution agents, 863 milk distributors, and 449 product distributors spread across 11 states.

    Competitive Advantages

  • A diverse product portfolio.
  • Leading dairy player in India’s southern region.
  • A solid distribution network.
  • A business model that is integrated with a strict quality control procedure.
  • An experienced board of directors and management team.

    • Company Promoters:

    Dodla Sunil Reddy, Dodla Sesha Reddy and Dodla Family Trust are the company promoters.

    Dodla Dairy IPO details
    Subscription Dates 16-18 June 2021
    Price Band 421 – 428 INR per share
    Fresh issue 50 crore
    Offer For Sale 10,985,444 shares (462.49 – 470.18 crore)
    Total IPO size 512.49 – 520.18 crore
    Minimum bid (lot size) 35 share
    Face Value 10 INR per share
    Retail Allocation 35%
    Listing On NSE, BSE
    Dodla Dairy Market Lot
    Lot No of Shares Amount
    Minimum 1 35 Shares 14,980 Rs
    Maximum 13 455 Shares 1,94,740 Rs

    Registrar of Dodla Dairy IPO

    KFin Technologies Private Limited
    Selenium Tower B, Plot 31-32,
    Gachibowli, Nanakramguda,
    Hyderabad – 500 032, Telangana
    Phone: +91 40 6716 2222
    Fax: +91 40 2343 1551
    Email: [email protected]
    Website: www.kfintech.com

    Dodla Dairy Contact Details

    Dodla Dairy Limited
    8-2-293/82/A/270-Q
    Road No. 10-C, Jubilee Hills
    Hyderabad – 500 033, Telangana
    Phone: +91 40 4546 7777
    Email: [email protected]
    Website: www.dodladairy.com

    Sona Comstar IPO Details, Price, Reviews

    Upcoming IPO

    Inaugurated In 1995, Sona BLW Precision Forgings (Sona Comstar) is an Indian automotive technology firm that specializes in the design, manufacture, and supply of highly engineered, mission-critical automotive systems and components. Differential assemblies, differential gears, conventional and micro-hybrid starter motors, BSG systems, EV traction motors (BLDC and PMSM), and motor control units are examples of these components.

    The company supplies both electrified and non-electrified powertrain segments to automotive OEMs in the United States, Europe, India, and China.

    Latest Ipo : Sona Comstar IPO Subscription Status Today [ Live ]

    Competitive Advantages

  • One of the world’s leading EV manufacturers and suppliers.
  • A diverse product portfolio.
  • Diversification of automotive geographies, vehicle segments, and customers.
  • Strong R&D (research and development) capabilities.
  • A track record of consistent financial performance.

    • Company Promoters:

    Sunjay Kapur, Sona Autocomp Holding Private Limited and Singapore VII Topco III Pte Ltd are the company promoters.

    Sona BLW IPO details
    Subscription Dates 14 – 16 June 2021
    Price Band 285 – 291 INR per share
    Fresh issue 300 crore
    Offer For Sale 5,700 crore
    Total IPO size 6000 crore
    Minimum bid (lot size) 51 share
    Face Value 10 INR per share
    Retail Allocation 35%
    Listing On NSE, BSE
    Sona BLW IPO Market Lot
    Lot No of Shares Amount
    Minimum 1 51 Shares 14,841 Rs
    Maximum 13 663 Shares 1,92,933 Rs

    Registrar of Sona BLW IPO

    KFin Technologies Private Limited
    Selenium Tower B, Plot 31-32,
    Gachibowli, Nanakramguda,
    Hyderabad – 500 032, Telangana
    Phone: +91 40 6716 2222
    Fax: +91 40 2343 1551
    Email: [email protected]
    Website: www.kfintech.com

    Sona BLW Contact Details

    Sona BLW Precision Forgings Limited
    Sona Enclave Village,
    Begumpur Khatola Sector 35, Gurugram
    Haryana – 122004
    Phone: +91 0124 476 8200
    Email: [email protected]
    Website: www.sonacomstar.com